查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
奎寧全球市場 - 全球產業分析、規模、份額、成長、趨勢、區域展望、預測 (2023-2030)
市場調查報告書
商品編碼
1385612

奎寧全球市場 - 全球產業分析、規模、份額、成長、趨勢、區域展望、預測 (2023-2030)

Quinine Market - Global Quinine Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030
出版日期: | 出版商: Fairfield Market Research | 英文 236 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

在健康意識和認可度不斷提高的推動下，全球奎寧市場規模預計在未來幾年將大幅成長。 該市場預計將從2022年的約21億美元成長到2030年的32億美元，2023年至2030年的複合年增長率為6.5%。

含有奎寧的湯力水作為一種健康飲料在世界各地越來越受歡迎。 由於奎寧具有治療瘧疾和緩解腿部抽筋等優異的治療特性，全球對湯力水的需求不斷增長，奎寧的市場正在擴大。

全球瘧疾病例數量正在迅速增加，2020年報告的新病例超過1400萬例，是自2012年以來的最高水準。 奎寧是治療瘧疾的有效藥物，隨著瘧疾患者的增加，預計需求也會增加。

奎寧是杜松子酒和滋補品等苦味酒精飲料的關鍵成分，在全球範圍內越來越受歡迎。 這一趨勢，加上啤酒、葡萄酒和烈酒等酒精飲料的日益普及，正在推動奎寧的銷售。

奎寧通常是作為酒精飲料的混合劑出售，但作為一種可用於多種用途的多功能產品並不廣為人知。 發燒、頭痛和視力問題等健康併發症與奎寧的消費有關，可能會影響市場成長。

本報告調查了全球奎寧市場，並提供了市場概況，包括按類型、應用、劑量、最終用戶、地區以及進入市場的公司的競爭趨勢劃分的趨勢。我是。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2030 年全球奎寧市場展望

  • 2018-2030 年全球奎寧市場前景（按類型和價值劃分）（百萬美元）
  • 2018-2030 年全球奎寧市場前景（按應用、金額（百萬美元））
  • 2018-2030 年全球奎寧市場展望（按劑量、價值（百萬美元））
  • 2018-2030 年全球奎寧市場展望，按最終用戶劃分，價值（百萬美元）
  • 2018-2030 年全球奎寧市場展望（按地區、價值（百萬美元））

第 4 章 2018-2030 年北美奎寧市場展望

第五章歐洲奎寧市場展望，2018-2030

第 6 章 2018-2030 年亞太地區奎寧市場展望

第 7 章拉丁美洲奎寧市場展望，2018-2030

第 8 章中東與非洲奎寧市場展望，2018-2030

第九章競爭態勢

  • 製造商和應用程式的熱圖
  • 2022 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Aecochem Corp
    • Haihang Industry Co. Ltd.
    • Actavis
    • Shreeji Pharma International
    • Wockhardt
    • Vital Labs
    • Trademax Pharmaceuticals & Chemicals
    • Van Wankum Ingredients
    • Hangzhou Dayang Co. Ltd.
    • IS Chemical Technology Ltd.
    • Leocorno Enterprises
    • Bickford & Sons
    • Fever-Tree
    • Schweppes
    • Chempro Pharma Private Limited

第 10 章附錄

簡介目錄

The global quinine market, driven by increasing health consciousness and rising awareness, is expected to witness substantial growth in the coming years. According to a recent report by Fairfield Market Research, the market was valued at approximately US$2.1 billion in 2022 and is projected to reach US$3.2 billion by 2030, with a CAGR of 6.5% between 2023 and 2030.

Market Drivers

Several key factors are contributing to the growth of the quinine market:

Increasing Demand for Tonic Water: Tonic water, containing quinine, is gaining popularity as a healthful beverage globally. With its exceptional therapeutic properties, including its use in malaria treatment and relieving leg cramps, quinine's market is expanding due to the rising global demand for tonic water.

Rising Cases of Malaria: The world has witnessed a surge in malaria cases, with over 14 million new cases reported in 2020, the highest levels since 2012. Quinine, an effective treatment for malaria, is expected to see increased demand due to the growing number of malaria patients.

Rising Alcoholic Beverage Consumption: Quinine is a key ingredient in some bitter alcoholic beverages like gin and tonic, which have gained popularity worldwide. This trend, along with the increasing popularity of alcoholic beverages like beer, wine, and spirits, is driving up the sales of quinine.

Market Challenges

Despite the promising growth, some challenges are impacting the quinine market:

Low Awareness Among Consumers: Quinine is often marketed as a mixer for alcoholic beverages, limiting its recognition as a versatile product with various uses.

Potential Health Issues: Some health complications, such as fever, headaches, and vision impairments, have been associated with quinine consumption, potentially affecting market growth.

Key Trends and Opportunities

The quinine market offers several opportunities for growth:

Product Innovations: Ongoing product innovation, including the use of quinine from natural sources and natural sweeteners, is expected to drive market expansion. Manufacturers are investing in research and development to create new flavors that cater to different consumer preferences.

Rising Consumer Spending Power: The increase in disposable income due to industrialization and economic progress is contributing to the growth of the quinine market. Urbanization and the influence of social media are also driving alcohol consumption and the demand for quinine.

Expanding Cocktail Culture: Tonic water is commonly used as a mixer in cocktails and mocktails, especially among gin and whisky drinkers. The growing cocktail culture is expected to open up new opportunities for the quinine sector.

Regional Outlook

North America: The North American region, including the U.S. and Canada, is expected to dominate the quinine market due to a high frequency of malaria and other mosquito-borne diseases. Additionally, the consumption of spirits like gin and tonic is on the rise.

Asia Pacific: The Asia Pacific region is projected to experience significant growth, driven by increased product approvals, rising awareness of malaria, and the consumption of spirits. India, China, and Indonesia are among the key markets driving demand.

Competitive Landscape

The quinine market is concentrated, with several major players driving innovation and expanding their distribution networks. Market consolidation is anticipated in the coming years. Some of the leading companies in the global quinine space include:

  • Aecochem Corp
  • Haihang Industry Co. Ltd.
  • Actavis
  • Shreeji Pharma International
  • Wockhardt
  • Vital Labs
  • Trademax Pharmaceuticals & Chemicals
  • Van Wankum Ingredients
  • Hangzhou Dayang Co. Ltd.
  • IS Chemical Technology Ltd.
  • Leocorno Enterprises
  • Bickford & Sons
  • Fever-Tree
  • Schweppes
  • Chempro Pharma Private Limited

Global Quinine Market is Segmented as Below:

By Type:

  • 200 mg
  • 300 mg
  • Other

By Application:

  • Problematic Leg Cramps
  • Malaria
  • Other

By Administration:

  • Oral Administration
  • Intramuscular Administration
  • Intravenous Administration
  • Others

By End User:

  • Hospitals
  • Clinics
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Quinine Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Quinine Market Outlook, 2018 - 2030

  • 3.1. Global Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. 200 mg
      • 3.1.1.2. 300 mg
      • 3.1.1.3. Other
  • 3.2. Global Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Problematic Leg Cramps
      • 3.2.1.2. Malaria
      • 3.2.1.3. Other
  • 3.3. Global Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oral Administration
      • 3.3.1.2. Intramuscular Administration
      • 3.3.1.3. Intravenous Administration
      • 3.3.1.4. Others
  • 3.4. Global Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights Snacks
      • 3.4.1.1. Hospitals
      • 3.4.1.2. Clinics
      • 3.4.1.3. Others
  • 3.5. Global Quinine Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Quinine Market Outlook, 2018 - 2030

  • 4.1. North America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. 200 mg
      • 4.1.1.2. 300 mg
      • 4.1.1.3. Other
  • 4.2. North America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Problematic Leg Cramps
      • 4.2.1.2. Malaria
      • 4.2.1.3. Other
  • 4.3. North America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oral Administration
      • 4.3.1.2. Intramuscular Administration
      • 4.3.1.3. Intravenous Administration
      • 4.3.1.4. Others
  • 4.4. North America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Clinics
      • 4.4.1.3. Others
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis
  • 4.5. North America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.2. U.S. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.3. U.S. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.4. U.S. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 4.5.1.5. Canada Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.6. Canada Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.7. Canada Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.8. Canada Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Quinine Market Outlook, 2018 - 2030

  • 5.1. Europe Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. 200 mg
      • 5.1.1.2. 300 mg
      • 5.1.1.3. Other
  • 5.2. Europe Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Problematic Leg Cramps
      • 5.2.1.2. Malaria
      • 5.2.1.3. Other
  • 5.3. Europe Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oral Administration
      • 5.3.1.2. Intramuscular Administration
      • 5.3.1.3. Intravenous Administration
      • 5.3.1.4. Others
  • 5.4. Europe Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Clinics
      • 5.4.1.3. Others
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis
  • 5.5. Europe Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.2. Germany Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.3. Germany Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.4. Germany Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.5. U.K. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.6. U.K. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.7. U.K. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.8. U.K. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.9. France Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.10. France Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.11. France Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.12. France Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.13. Italy Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.14. Italy Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.15. Italy Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.16. Italy Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.17. Turkey Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.18. Turkey Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.19. Turkey Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.20. Turkey Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.21. Russia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.22. Russia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.23. Russia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.24. Russia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.25. Rest of Europe Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.26. Rest of Europe Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.27. Rest of Europe Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.28. Rest of Europe Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Quinine Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. 200 mg
      • 6.1.1.2. 300 mg
      • 6.1.1.3. Other
  • 6.2. Asia Pacific Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Problematic Leg Cramps
      • 6.2.1.2. Malaria
      • 6.2.1.3. Other
  • 6.3. Asia Pacific Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oral Administration
      • 6.3.1.2. Intramuscular Administration
      • 6.3.1.3. Intravenous Administration
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Clinics
      • 6.4.1.3. Others
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis
  • 6.5. Asia Pacific Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.2. China Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.3. China Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.4. China Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.5. Japan Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.6. Japan Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.7. Japan Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.8. Japan Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.9. South Korea Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.10. South Korea Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.11. South Korea Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.12. South Korea Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.13. India Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.14. India Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.15. India Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.16. India Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.17. Southeast Asia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.18. Southeast Asia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.19. Southeast Asia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.20. Southeast Asia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.21. Rest of Asia Pacific Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.22. Rest of Asia Pacific Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.23. Rest of Asia Pacific Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.24. Rest of Asia Pacific Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Quinine Market Outlook, 2018 - 2030

  • 7.1. Latin America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. 200 mg
      • 7.1.1.2. 300 mg
      • 7.1.1.3. Other
  • 7.2. Latin America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Problematic Leg Cramps
      • 7.2.1.2. Malaria
      • 7.2.1.3. Other
  • 7.3. Latin America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oral Administration
      • 7.3.1.2. Intramuscular Administration
      • 7.3.1.3. Intravenous Administration
      • 7.3.1.4. Others
  • 7.4. Latin America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Clinics
      • 7.4.1.3. Others
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis
  • 7.5. Latin America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.2. Brazil Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.3. Brazil Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.4. Brazil Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.5. Mexico Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.6. Mexico Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.7. Mexico Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.8. Mexico Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.9. Argentina Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.10. Argentina Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.11. Argentina Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.12. Argentina Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.13. Rest of Latin America Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.14. Rest of Latin America Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.15. Rest of Latin America Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.16. Rest of Latin America Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Quinine Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. 200 mg
      • 8.1.1.2. 300 mg
      • 8.1.1.3. Other
  • 8.2. Middle East & Africa Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Problematic Leg Cramps
      • 8.2.1.2. Malaria
      • 8.2.1.3. Other
  • 8.3. Middle East & Africa Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oral Administration
      • 8.3.1.2. Intramuscular Administration
      • 8.3.1.3. Intravenous Administration
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Clinics
      • 8.4.1.3. Others
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Middle East & Africa Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.2. GCC Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.3. GCC Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.4. GCC Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.5. South Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.6. South Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.7. South Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.8. South Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.9. Egypt Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.10. Egypt Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.11. Egypt Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.12. Egypt Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.13. Nigeria Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.14. Nigeria Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.15. Nigeria Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.16. Nigeria Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.17. Rest of Middle East & Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.18. Rest of Middle East & Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.19. Rest of Middle East & Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.20. Rest of Middle East & Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs Application Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Aecochem Corp
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Haihang Industry Co. Ltd.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Actavis
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Shreeji Pharma International
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Wockhardt
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Vital Labs
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Trademax Pharmaceuticals & Chemicals
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Van Wankum Ingredients
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Hangzhou Dayang Co. Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Business Strategies and Development
    • 9.4.10. IS Chemical Technology Ltd.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Leocorno Enterprises
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Bickford & Sons
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Fever-Tree
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Schweppes
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Chempro Pharma Private Limited
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations